Kurs & Likviditet
|Lista||First North Denmark|
|Industri||Vård & Omsorg|
|2022-09-02||Extra Bolagsstämma 2022|
|2022-05-19||Ordinarie utdelning BRAINP 0.00 DKK|
BRAIN+ A/S (BRAINP)
Company Announcement No. 3-2021
Tuesday November 16, 2021, 22:05 CET
Kim Arvid Nielsen, who has served as a Board member at Brain+ for about 2 years has chosen to focus his time and to go full time into his orignial profession of being a medical doctor/general practitioner. Kim A. has therefore decided to announce his intention to leave his position as Board member but will continue to serve on the Board until his replacement is found.
Lars Terney, Chairman of the Board, comments: "The board would like to thank Kim A. for his contributions and wholeheartedly respect Kim A's assessment that the time requirement of the Brain+ board work is non compatible with his future career aspirations. We wish Kim A. all the best in the future and thank him profoundly for his contributions."
This press release constitutes inside information that Brain+ A/S is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was sent for publication, through the agency of the contact persons set out below, at the time stated by the Company's news distributor, Cision, at the publication of this press release.
CEO, Kim Baden-Kristensen + 45 31393318
Købmagergade 53, 3.
Keswick Global AG
+ 43 1 740 408045
About BRAIN+ [BRAINP]
The mission of Brain+ is to restore patients' independence and quality of life by treating and detecting cognitive decline in Alzheimer's disease and dementia through digital means. Brain+ has developed a set of Digital Medicine technologies, which enable the Company to create a unique and differentiated product offering. These technologies, combined with a strong clinical pipeline, Brain+ is in a strong position to grow towards a market leader position in the major Digital Medicine space.